Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder
- 1 December 2019
- journal article
- Published by Longdom Group in Clinical Schizophrenia & Related Psychoses
- Vol. 12 (4) , 168-176
Abstract
The goal of this 21-year naturalistic study of clozapine treated patients was to examine the cardiovascular risk factors following clozapine initiation and resultant mortality estimates from cardiovascular disease. Data was collected from medical records of clozapine treated patients with schizophrenia or schizoaffective disorder from January 1992 to February 2012. Demographics, clozapine dosage and laboratory results were extracted at 12-month intervals. At clozapine initiation, the mean age of 96 patients was 36.4 years ±7.6 years; N=27(28%) were women. The mean duration of clozapine use was 13 years. The Kaplan-Meier estimate for 21-year cardiovascular events was 29%, while the Kaplan-Meier estimate for 21-year mortality from cardiovascular disease was 10%. The mean cardiovascular risk increased during the first ten years (p<.01), while a slight decrease occurred beyond ten years (p<.01). Patients involved in cardiometabolic research showed a greater decrease in cardiovascular risk factors ove...Keywords
This publication has 14 references indexed in Scilit:
- Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment AlgorithmNeuropsychopharmacology, 2011
- Heart disease treatment and mortality in schizophrenia and bipolar disorder – Changes in the danish population between 1994 and 2006Journal of Psychiatric Research, 2011
- Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With ClozapineThe Journal of Clinical Psychiatry, 2010
- Comorbid Somatic Illnesses in Patients With Severe Mental DisordersThe Journal of Clinical Psychiatry, 2008
- Physical illness and schizophrenia: a review of the literatureActa Psychiatrica Scandinavica, 2007
- Schizophrenia and increased risks of cardiovascular diseaseAmerican Heart Journal, 2005
- Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and MortalityThe Journal of Clinical Psychiatry, 2005
- Arterial Stiffness and Stroke in HypertensionCNS Drugs, 2005
- Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic StudyAmerican Journal of Psychiatry, 2000
- Epidemiology of cardiovascular disease in the United StatesAmerican Journal of Kidney Diseases, 1998